Safilo Group S.p.A. (SAFLF)
USD 0.98
(0.0%)
USD 0.98
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 157.59 Million EUR | -17.53% |
| 2022 | 191.1 Million EUR | -0.96% |
| 2021 | 192.96 Million EUR | -37.96% |
| 2020 | 311.03 Million EUR | 123.65% |
| 2019 | 139.07 Million EUR | -34.13% |
| 2018 | 211.12 Million EUR | 1.55% |
| 2017 | 207.9 Million EUR | 32.08% |
| 2016 | 157.4 Million EUR | -10.84% |
| 2015 | 176.54 Million EUR | -29.89% |
| 2014 | 251.81 Million EUR | -5.01% |
| 2013 | 265.1 Million EUR | -3.49% |
| 2012 | 274.67 Million EUR | -16.42% |
| 2011 | 328.63 Million EUR | -4.59% |
| 2010 | 344.43 Million EUR | 93.37% |
| 2009 | 178.12 Million EUR | -71.44% |
| 2008 | 623.72 Million EUR | 9.13% |
| 2007 | 571.53 Million EUR | 473.39% |
| 2006 | 99.67 Million EUR | -45.83% |
| 2005 | 184 Million EUR | 49.62% |
| 2004 | 122.98 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 104.17 Million EUR | 6.75% |
| 2024 Q1 | 133 Million EUR | -15.6% |
| 2023 Q4 | 157.59 Million EUR | 6.52% |
| 2023 Q1 | 164.7 Million EUR | -13.82% |
| 2023 Q3 | 147.95 Million EUR | -15.1% |
| 2023 Q2 | 174.27 Million EUR | 5.81% |
| 2023 FY | 157.59 Million EUR | -17.53% |
| 2022 Q3 | 182.05 Million EUR | -1.19% |
| 2022 Q4 | 191.1 Million EUR | 4.97% |
| 2022 FY | 191.1 Million EUR | -0.96% |
| 2022 Q1 | 175.83 Million EUR | -8.88% |
| 2022 Q2 | 184.24 Million EUR | 4.78% |
| 2021 Q2 | 298.09 Million EUR | 3.06% |
| 2021 Q3 | 184.71 Million EUR | -38.03% |
| 2021 Q1 | 289.23 Million EUR | -7.01% |
| 2021 Q4 | 192.96 Million EUR | 4.46% |
| 2021 FY | 192.96 Million EUR | -37.96% |
| 2020 Q1 | 288.97 Million EUR | 107.79% |
| 2020 Q3 | 301.43 Million EUR | 0.67% |
| 2020 Q2 | 299.4 Million EUR | 3.61% |
| 2020 FY | 311.03 Million EUR | 123.65% |
| 2020 Q4 | 311.03 Million EUR | 3.19% |
| 2019 Q1 | 133.71 Million EUR | -36.67% |
| 2019 Q3 | 129.35 Million EUR | -9.51% |
| 2019 Q2 | 142.94 Million EUR | 6.91% |
| 2019 FY | 139.07 Million EUR | -34.13% |
| 2019 Q4 | 139.07 Million EUR | 7.51% |
| 2018 Q3 | 211.12 Million EUR | -25.68% |
| 2018 Q1 | 284.07 Million EUR | 36.64% |
| 2018 FY | 211.12 Million EUR | 1.55% |
| 2018 Q4 | 211.12 Million EUR | -0.0% |
| 2018 Q2 | 284.07 Million EUR | 0.0% |
| 2017 Q2 | 190.92 Million EUR | 0.0% |
| 2017 Q1 | 190.92 Million EUR | 21.29% |
| 2017 FY | 207.9 Million EUR | 32.08% |
| 2017 Q4 | 207.9 Million EUR | 0.0% |
| 2017 Q3 | 207.9 Million EUR | 8.89% |
| 2016 Q1 | 174.8 Million EUR | -0.99% |
| 2016 FY | 157.4 Million EUR | -10.84% |
| 2016 Q4 | 157.4 Million EUR | 0.0% |
| 2016 Q3 | 157.4 Million EUR | -9.95% |
| 2016 Q2 | 174.8 Million EUR | 0.0% |
| 2015 Q3 | 178.94 Million EUR | -5.9% |
| 2015 Q4 | 176.54 Million EUR | -1.34% |
| 2015 Q2 | 190.16 Million EUR | -7.38% |
| 2015 FY | 176.54 Million EUR | -29.89% |
| 2015 Q1 | 205.32 Million EUR | -18.46% |
| 2014 Q3 | 258.4 Million EUR | 0.63% |
| 2014 Q4 | 251.81 Million EUR | -2.55% |
| 2014 Q1 | 287.36 Million EUR | 8.4% |
| 2014 FY | 251.81 Million EUR | -5.01% |
| 2014 Q2 | 256.79 Million EUR | -10.64% |
| 2013 Q4 | 265.1 Million EUR | 2.83% |
| 2013 FY | 265.1 Million EUR | -3.49% |
| 2013 Q3 | 257.8 Million EUR | -4.87% |
| 2013 Q2 | 271.01 Million EUR | -7.28% |
| 2013 Q1 | 292.29 Million EUR | 6.41% |
| 2012 Q2 | 287.31 Million EUR | -11.64% |
| 2012 Q4 | 274.67 Million EUR | -7.24% |
| 2012 FY | 274.67 Million EUR | -16.42% |
| 2012 Q1 | 325.15 Million EUR | -1.06% |
| 2012 Q3 | 296.12 Million EUR | 3.07% |
| 2011 FY | 328.63 Million EUR | -4.59% |
| 2011 Q1 | 337.56 Million EUR | -2.0% |
| 2011 Q2 | 339.54 Million EUR | 0.59% |
| 2011 Q3 | 343.91 Million EUR | 1.29% |
| 2011 Q4 | 328.63 Million EUR | -4.44% |
| 2010 FY | 344.43 Million EUR | 93.37% |
| 2010 Q1 | 58.8 Million EUR | -66.99% |
| 2010 Q2 | 64.04 Million EUR | 8.91% |
| 2010 Q4 | 344.43 Million EUR | 529.71% |
| 2010 Q3 | 54.69 Million EUR | -14.59% |
| 2009 Q4 | 178.12 Million EUR | 0.0% |
| 2009 FY | 178.12 Million EUR | -71.44% |
| 2008 FY | 623.72 Million EUR | 9.13% |
| 2007 FY | 571.53 Million EUR | 473.39% |
| 2006 FY | 99.67 Million EUR | -45.83% |
| 2005 FY | 184 Million EUR | 49.62% |
| 2004 FY | 122.98 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 500 Thousand USD | -31419.4% |
| Ansell Limited | 855.59 Million USD | 81.58% |
| Ansell Limited | 857.2 Million USD | 81.615% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -603.195% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 20.93 Thousand USD | -752691.975% |
| Psykey, Inc. | 1.01 Million USD | -15494.399% |
| ConvaTec Group Plc | 1.31 Billion USD | 87.975% |
| ConvaTec Group Plc | 1.31 Billion USD | 87.992% |
| Encision Inc. | 1.33 Million USD | -11720.939% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -6726.172% |
| Innovative MedTech Inc. | 1.87 Million USD | -8290.741% |
| LifePoint, Inc. | 446.74 Thousand USD | -35177.119% |
| Medite Cancer Diagnostics, Inc. | 5.39 Million USD | -2821.611% |
| Paradigm Medical Industries, Inc. | 2.18 Million USD | -7099.497% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 242.64 Thousand USD | -64849.885% |
| SmileDirectClub, Inc. | 871.79 Million USD | 81.923% |
| Sector 10, Inc. | 164 Thousand USD | -95995.732% |
| Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 76.618% |
| SheerVision, Inc. | 75 Thousand USD | -210029.333% |
| United Health Products, Inc. | 755.98 Thousand USD | -20746.467% |
| Vasamed, Inc. | 23.45 Thousand USD | -671955.437% |
| Wearable Health Solutions, Inc. | 2.76 Million USD | -5594.829% |
| Yubo International Biotech Limited | 790.49 Thousand USD | -19836.395% |